Insight Molecular Diagnostics

IMDX

Börsenwert 81,8 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	10,4 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	470.000 $	-125.098 $	-3.478	-17 %
3	3 Bridgeway Capital Management Houston, Texas	269.000 $	-188.834 $	-5.250	-35 %
4	4 BlackRock New York	91.000 $	–	–	–
5	5 Destination Wealth Management Walnut Creek, California	41.000 $	–	–	–
6	6 Morgan Stanley New York	41.000 $	+396 $	+11	+0,8 %
7	7 Commonwealth Equity Services Waltham, Massachusetts	40.000 $	+9.064 $	+252	+21 %
8	8 Geode Capital Management Boston, Massachusetts	21.000 $	–	–	–
9	9 Williams Jones & Associates New York	21.000 $	–	–	–
10	10 Northern Trust Chicago, Illinois	20.000 $	–	–	–
11	11 Janney Montgomery Scott Philadelphia, Pennsylvania	17.000 $	-180 $	-5	-0,8 %
12	12 Tower Research Capital (TRC) New York	3.000 $	+4.496 $	+125	Neu
13	13 UBS Group Zurich, Switzerland	2.000 $	+3.237 $	+90	Neu
14	14 Ladenburg Thalmann Financial Services Miami, Florida	1.000 $	–	–	–
15	15 BNP Paribas Financial Markets Paris, France	217 $	–	–	–
16	AG 16 Artal Group Luxembourg	–	-375.000 $	-7.500	Geschlossen
17	17 Element Capital Management New York	–	-114.000 $	-2.284	Geschlossen
18	18 Millennium Management New York	–	-79.000 $	-1.579	Geschlossen
19	19 Royal Bank of Canada Toronto, Ontario, Canada	–	-9.028 $	-251	-93 %
20	20 Bank of Montreal Toronto, Ontario, Canada	–	-3.000 $	-67	Geschlossen
21	21 Carroll Financial Associates Charlotte, North Carolina	–	-2.000 $	-43	Geschlossen
22	22 Wells Fargo San Francisco, California	–	-108 $	-3	-60 %

Insight Molecular Diagnostics IMDX Börsenwert 81,8 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 81,8 Mio. $